Universal Beteiligungs und Servicegesellschaft mbH Purchases 88,124 Shares of Bruker Corporation $BRKR

Universal Beteiligungs und Servicegesellschaft mbH increased its holdings in Bruker Corporation (NASDAQ:BRKR) by 19.0% during the 2nd quarter, Holdings Channel reports. The firm owned 552,153 shares of the medical research company’s stock after buying an additional 88,124 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Bruker were worth $22,749,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the business. Amundi grew its position in shares of Bruker by 373.3% in the 1st quarter. Amundi now owns 42,503 shares of the medical research company’s stock worth $1,774,000 after buying an additional 33,522 shares during the last quarter. Vaughan Nelson Investment Management L.P. lifted its stake in Bruker by 71.2% in the second quarter. Vaughan Nelson Investment Management L.P. now owns 1,293,645 shares of the medical research company’s stock worth $53,298,000 after acquiring an additional 537,845 shares during the period. Wealth Enhancement Advisory Services LLC boosted its holdings in Bruker by 35.6% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 40,450 shares of the medical research company’s stock valued at $1,717,000 after acquiring an additional 10,624 shares in the last quarter. Public Employees Retirement System of Ohio increased its position in Bruker by 60.8% during the 2nd quarter. Public Employees Retirement System of Ohio now owns 55,672 shares of the medical research company’s stock valued at $2,294,000 after purchasing an additional 21,043 shares during the period. Finally, State of New Jersey Common Pension Fund D raised its holdings in Bruker by 39.0% in the 2nd quarter. State of New Jersey Common Pension Fund D now owns 51,828 shares of the medical research company’s stock worth $2,135,000 after purchasing an additional 14,547 shares in the last quarter. Hedge funds and other institutional investors own 79.52% of the company’s stock.

Insider Activity

In other Bruker news, Director Cynthia M. Friend sold 3,535 shares of Bruker stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $32.25, for a total value of $114,003.75. Following the completion of the transaction, the director directly owned 18,016 shares of the company’s stock, valued at approximately $581,016. The trade was a 16.40% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director John A. Ornell sold 6,233 shares of the stock in a transaction that occurred on Thursday, November 6th. The shares were sold at an average price of $39.00, for a total transaction of $243,087.00. Following the sale, the director owned 35,212 shares in the company, valued at approximately $1,373,268. The trade was a 15.04% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 27.30% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on BRKR shares. Barclays boosted their price target on shares of Bruker from $40.00 to $45.00 and gave the company an “overweight” rating in a research report on Tuesday, November 4th. Wells Fargo & Company cut their price objective on Bruker from $50.00 to $48.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 5th. Jefferies Financial Group set a $60.00 target price on Bruker and gave the stock a “buy” rating in a research report on Monday, August 4th. Citigroup dropped their price target on Bruker from $40.00 to $38.00 and set a “neutral” rating on the stock in a research report on Monday, August 4th. Finally, TD Cowen upped their price target on Bruker from $40.00 to $42.00 and gave the stock a “hold” rating in a research note on Tuesday, November 4th. Five equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Bruker presently has a consensus rating of “Hold” and a consensus price target of $48.30.

Bruker Stock Performance

Shares of BRKR opened at $42.66 on Wednesday. The company has a quick ratio of 0.70, a current ratio of 1.61 and a debt-to-equity ratio of 1.31. The stock has a market cap of $6.48 billion, a P/E ratio of 82.04, a P/E/G ratio of 5.31 and a beta of 1.25. The business’s 50 day moving average price is $36.49 and its 200-day moving average price is $37.18. Bruker Corporation has a 52 week low of $28.53 and a 52 week high of $64.64.

Bruker (NASDAQ:BRKR) last posted its quarterly earnings data on Monday, November 3rd. The medical research company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.33 by $0.12. The company had revenue of $860.50 million during the quarter, compared to analyst estimates of $847.40 million. Bruker had a return on equity of 17.89% and a net margin of 2.31%.The firm’s revenue for the quarter was down .5% on a year-over-year basis. During the same quarter last year, the company earned $0.60 EPS. Bruker has set its FY 2025 guidance at 1.850-1.90 EPS. Equities research analysts anticipate that Bruker Corporation will post 2.69 earnings per share for the current fiscal year.

Bruker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 2nd. Investors of record on Monday, December 8th will be paid a $0.05 dividend. The ex-dividend date is Monday, December 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.5%. Bruker’s payout ratio is presently -125.00%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.